Get started
Author

Mercedes Salgado

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
2018 · Andrés J. Muñoz Martín, Israel Ortega, et al. · British Journal of Cancer · 141
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
2023 · Andrés Muñoz, Cihan Ay, et al. · Journal of Clinical Oncology · 71
PDF
A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
2014 · Carlos Gomez-Martín, Fernando Lopez-Rios, et al. · Cancer Letters · 68
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
2017 · Jean-François Emile, Catherine Julié, et al. · European Journal of Cancer · 49
From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer
2018 · Andrés Muñoz Martín, Manuel Hidalgo, et al. · Journal of Cancer · 42
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
2016 · M. Hidalgo, R. Álvarez, et al. · Clinical & Translational Oncology · 40
PDF
Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors
2021 · Izidor Mlakar, Simon Lin, et al. · BMC Medical Informatics and Decision Making · 37
PDF
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
2016 · R. Vera, E. Dotor, et al. · Clinical & Translational Oncology · 37
PDF
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
2018 · Ana Fernández, Mercedes Salgado, et al. · BMC Cancer · 35
PDF
Clinical guideline SEOM: hepatocellular carcinoma
2015 · J. Sastre, R. Díaz-Beveridge, et al. · Clinical & Translational Oncology · 33
PDF
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
2014 · Julen Fernandez-Plana, Carlos Pericay, et al. · BMC Cancer · 24
PDF
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
2010 · R López, M Salgado, et al. · British Journal of Cancer · 16
PDF
Comparative analysis of capture methods for genomic profiling of circulating tumor cells in colorectal cancer
2022 · Joao M. Alves, Nuria Estévez-Gómez, et al. · Genomics · 12
PDF
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)
2018 · Pilar García-Alfonso, Manuel Benavides, et al. · The Oncologist · 12
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study
2020 · Ruth Vera, María Luisa Gómez, et al. · Cancers · 11
PDF
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
2020 · Ruth Vera, Elena Mata, et al. · International Journal of Colorectal Disease · 11
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
2023 · M. Toledano-Fonseca, M.A. Gómez-España, et al. · Biomedicine & Pharmacotherapy · 10
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
2019 · G. Quintero Aldana, M. Salgado, et al. · Clinical & Translational Oncology · 10
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study
2008 · Jaime Feliu, Jose Luis Firvida, et al. · Cancer Chemotherapy and Pharmacology · 10
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
2022 · Manuel Valladares-Ayerbes, Pilar Garcia-Alfonso, et al. · Cancers · 9
PDF
Docetaxel plus fractionated cisplatin is a safe and active schedule as first-line treatment of patients with advanced non-small cell lung cancer: Results of a phase II study
2004 · José Luis Firvida, Margarita Amenedo, et al. · Investigational New Drugs · 9
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
2021 · Elena Élez, María Auxiliadora Gómez-España, et al. · British Journal of Cancer · 8
PDF
Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España
2015 · Juan Turnes, Roberto Díaz, et al. · Gastroenterología y Hepatología · 8
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
2015 · G. Quintero-Aldana, M. Jorge, et al. · Cancer Chemotherapy and Pharmacology · 7
What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study
2023 · Yolanda Escobar, Avinash Ramchandani, et al. · Clinical & Translational Oncology · 6
Works count: 63
Citation count: 759
H-index: 12
I10-index: 19
Year
Topic
Type